A61P 5 - Drugs for disorders of the endocrine system

Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
12/2011
12/22/2011	US20110312950 CYCLIC INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
12/22/2011	US20110312944 Heterocyclic Compounds Which Modulate The CB2 Receptor
12/22/2011	US20110312911 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
12/22/2011	US20110312906 Treatment or reduction of menopausal symptoms
12/22/2011	US20110312881 Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases
12/22/2011	US20110312878 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/22/2011	US20110311531 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/22/2011	US20110311526 Polynucleotide and polypeptide sequences involved in the process of bone remodeling
12/22/2011	US20110311507 Methods for Diagnosing and Treating Autoimmune Disorders
12/22/2011	US20110311483 Crth2 modulators
12/22/2011	US20110308985 Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof
12/22/2011	CA2802761A1 Methods of treating or preventing estrogen-related diseases
12/22/2011	CA2801182A1 Gpr120 receptor agonists and uses thereof
12/21/2011	EP2396034A1 Antibodies and methods for treating estrogen receptor-associated diseases
12/21/2011	EP2395975A1 An oral pharmaceutical composition of dutasteride
12/21/2011	EP2091922B1 2-[1-phenyl-5-hydroxy-4alpha-methyl-hexahydrocyclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
12/21/2011	CN102286064A 具有胰岛素增敏活性的化合物及其制备方法和用途 Have insulin-sensitizing activity of compounds and their preparation and use
12/21/2011	CN102286057A 齐墩果烷型三帖类化合物及其制备方法和医疗用途 Oleanane type triterpenes compound and its preparation method and medical use
12/21/2011	CN102285933A 一种对亚型过氧化物酶增殖物激活受体具有激动作用的化合物、其制备方法和应用 A compound of the subtype of peroxisome proliferator-activated receptor agonism, and its preparation method and application
12/21/2011	CN102283981A 一种治疗甲亢的药物及其制备方法 An hyperthyroidism and preparation method of treatment
12/21/2011	CN102283256A 一种八角茴香杀线虫提取物及其制备方法 Nematicide one kind of star anise extract and its preparation method
12/21/2011	CN102018928B 一种治疗甲状腺功能减退症的中药制备方法 A treatment for hypothyroidism herbal preparation
12/20/2011	US8080636 BSL3 antibodies
12/20/2011	CA2524409C Androgen receptor modulators and methods of use thereof
12/15/2011	WO2011155641A1 Method for producing erythropoietin, and method for isolating erythropoietin-producing cells
12/15/2011	WO2011153583A1 Nociceptin mimetics
12/15/2011	US20110306548 Stable growth hormone compounds
12/15/2011	US20110306544 Methods and formulations for increasing intestinal function
12/15/2011	US20110305782 Methods of cholesterol reduction using isoflavones
12/15/2011	US20110305771 Krill Extracts for Treatment of Cardiovascular Diseases
12/15/2011	US20110305634 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
12/14/2011	EP2395021A1 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
12/14/2011	EP2240198B1 Composition for absorption through mucous tissue
12/14/2011	EP1587479B1 Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
12/14/2011	EP1532122B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/14/2011	CN102274468A 一种调节女性内分泌的中药组合物及其制备方法 A method of adjusting the female endocrine medicine composition and its preparation method
12/14/2011	CN102274390A 用于高雄激素型多囊卵巢综合征的药物组合物 Pharmaceutical compositions for polycystic ovary syndrome, hyperandrogenism
12/14/2011	CN102274267A 真空包装太子参制备方法 Vacuum packaging Taizishen preparation
12/14/2011	CN102068429B 法倔唑在诱导罗非鱼已分化卵巢转变为功能型精巢中的应用及其诱导方法 Fadrozole tilapia differentiated ovarian induction into the application of functional testis and induction methods
12/13/2011	US8076412 Water-soluble polymer alkanals
12/13/2011	US8076367 Benzimidazolylidene propane-1,3-dione derivative or salt thereof
12/13/2011	US8076317 administering contraceptives comprising hormones in cycles
12/13/2011	CA2449578C Pyrrolidine oxadiazole- and thiadiazole derivatives
12/08/2011	WO2011151833A1 Methods of treating diabetes and compositions capable of same
12/08/2011	US20110301203 Chemical compounds
12/08/2011	US20110301158 Aryl carbonyl derivatives as therapeutic agents
12/08/2011	US20110301143 Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/08/2011	US20110301128 Pyrrole Derivatives As Pharmaceutical Agents
12/08/2011	US20110301096 Prodrug of an ice inhibitor
12/08/2011	US20110300145 Interferon Alpha Antibodies And Their Uses
12/08/2011	US20110300138 Human anti tshr antibodies
12/07/2011	EP2392322A2 Dosing regimes for trans-clomiphene
12/07/2011	EP1667521B1 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency
12/07/2011	CN102272119A 作为沉默调节蛋白调节剂的吡啶、双环吡啶和相关的类似物 As a sirtuin modulator of pyridine, pyridine and related bicyclic analogs
12/07/2011	CN102271701A 具有脂类动员性质的糖蛋白及其治疗用途 Glycoprotein lipid mobilizing its therapeutic use have properties
12/07/2011	CN102266485A 黄精水提物在制备雌激素药物中的应用 Huang Jing water extract used in the preparation of estrogen drugs
12/07/2011	CN102266359A 一种从卷柏中连续提取降血糖活性成分和雌激素活性成分的方法 A continuous extraction method from Selaginella in hypoglycemic active ingredients and estrogen active ingredients
12/07/2011	CN102266324A 一种κ-阿片受体激动剂的新用途 The new use of a κ- opioid receptor agonist
12/07/2011	CN102266176A 一种药草保健床垫床褥 Herb health mattress mattress
12/06/2011	US8071729 Anti-integrin antibodies, compositions, methods and uses
12/06/2011	US8071621 Alkylsulphonamide quinolines
12/06/2011	US8071589 Dihydrobenzoindazoles
12/06/2011	US8071576 Fewer side effects; usable for longer period of time; lower recurrence rates after discontinuation; combination of progestogen and androgen components; kits
12/06/2011	US8071333 Anti-integrin antibodies, compositions, methods and uses
12/06/2011	CA2455620C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/06/2011	CA2328783C Human procalcitonin and the preparation and use thereof
12/01/2011	WO2011148922A1 Novel quinazoline compound
12/01/2011	WO2011147980A1 Pharmaceutical composition comprising ave0010 and insulin glargine
12/01/2011	WO2011147889A1 Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient
12/01/2011	WO2011147086A1 Microvesicles carrying small interfering rnas, preparation methods and uses thereof
12/01/2011	US20110294876 Cyclohexyl carbamate compounds as anti-ageing actives
12/01/2011	US20110294856 Novel oxadiazole derivatives and their medical use
12/01/2011	US20110294809 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1
12/01/2011	US20110294781 Pyrazolo-pyrimidine compounds
12/01/2011	US20110294780 SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS
12/01/2011	US20110294770 Method for producing pharmaceutical drug particles of small particle size
12/01/2011	US20110294759 Once daily formulations of tetracyclines
12/01/2011	US20110294758 Novel activators of glucokinase
12/01/2011	US20110293711 Utilization of Dialkylfumarates
12/01/2011	US20110293647 Immunogenic lhrh compositions and methods relating thereto
12/01/2011	US20110293564 2-morpholino-pyrido[3,2-d]pyrimidines
11/2011
11/30/2011	EP2390260A2 Ester derivative of ethinyl estradiol
11/30/2011	EP2389945A1 Pharmaceutical composition comprising AVE0010 and insulin glargine
11/30/2011	CN1919277B 一种药物组合物在制备增强胰岛素敏感性药物中的应用 A pharmaceutical composition in the manufacture of a medicament for enhancing insulin sensitivity Application
11/30/2011	CN102264362A 预防或治疗与更年期有关的症状的植物雌激素组合物 Prevention or treatment of symptoms associated with menopause, phytoestrogens composition
11/30/2011	CN102258783A Gsk3抑制剂在制备治疗高雄激素血症药物中的用途 Gsk3 inhibitor in the preparation of a medicament for the treatment of hyperandrogenism uses
11/29/2011	US8067569 Splice-region antisense composition and method
11/29/2011	US8067554 separating speptide and related impurities by elution in a solution comprising an organic modifier, water, optionally a salt component, and a buffer, with a linear or step gradient or isocratically in salt component and/or with a linear or step pH-gradient or at a constant pH value
11/29/2011	US8067034 contains whey as the active component; prevent or ameliorate various symptoms, such as sleep disorder or prolonged sleep latency
11/29/2011	US8067030 Controlled release composition and method of producing the same
11/29/2011	US8067020 Sustained release formulation
11/29/2011	US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/29/2011	CA2641581C Stabilization of solid thyroid drug formulations
11/29/2011	CA2479711C Formulation
11/29/2011	CA2401241C 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
11/24/2011	WO2011144673A2 Long - acting formulations of insulins
11/24/2011	WO2011144327A1 Posology and administration of glucocorticoid based compositions
11/24/2011	WO2011029088A3 Preparation of raloxifene and its salts
11/24/2011	WO2010097576A8 1, 4-disubstituted piperidines as vasopressin receptor via antagonists
11/24/2011	US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof

1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 290